Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 116   

Articles published

4502 4,823.00 -22.00 (-0.45%)
price chart
Takeda Announces Bold, New Access to Medicines Strategy
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and potentially life-saving medicines ...
Takeda announces Access to Medicines strategy: 5 notes  Becker's ASC Review
Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership ...
Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. (TSE:4502) from the realm of small molecule discovery into the new research area of antibody drug discovery. All three ...
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Takeda and PRA Health Sciences Announce Transformational Clinical Development ...
OSAKA, Japan & RALEIGH, N.C.--(BUSINESS WIRE)--PRA Health Sciences, Inc. (NASDAQ: PRAH) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have entered into a new partnership agreement under ...
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA ...
BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that the Phase 3 ALCANZA clinical trial evaluating ...
Business Briefs: Takeda Pharmaceutical Company to Develop Zika Vaccine
Takeda Pharmaceutical Company Ltd. announced that the Biomedical Advanced Research and Development Authority has selected Takeda's Vaccine Business Unit to develop a vaccine to support the Zika response in the U.S.
Takeda Named To 2016 Working Mother "100 Best Companies" For Leadership In ...
Takeda Pharmaceutical Company Limited is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Takeda Announces Winners From Its Depression Care Challenge Competition
DEERFIELD, Ill., Sept. 28, 2016 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, today announced the winners of its Open Innovation in Depression Care Crowd Challenge, ...
Takeda and Zydus Cadila partner to address the global threat of Chikungunya
OSAKA, Japan & AHMEDABAD, India--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the ...
Zydus Cadila partners Takeda for chikungunya vaccine  The Indian Express
Zydus Cadila ties up with Takeda to develop chikungunya vaccine  Hindu Business Line
Takeda Launches Wearable Digital Technology Pilot Program to Support Patients ...
Takeda Pharmaceuticals U.S.A., Inc. is located in Deerfield, Ill., and is the U.S. marketing and sales organization of Takeda Pharmaceutical Company Limited. Additional information about Takeda is available through its corporate website, www.takeda.com ...